Analyst Sees Multi-Billion-Dollar Sales Potential for Zura Bio’s Lead Therapy
On Wednesday, William Blair initiated coverage of Zura Bio Limited (NASDAQ:ZURA) with an Outperform rating, citing the potential of its lead …
Read from Source · benzinga.com ↗
This content is automatically aggregated. Full credit goes to the original publisher (benzinga.com).
